Filing
Spy
Filing
Spy
Home
About
RCKT
Rocket Pharmaceuticals Inc
Biotechnology company developing gene therapies for rare diseases
CUSIP: 77313F106
Healthcare
US
1 holder
Ownership
Activity
2024 Q2
7 of 19 quarters
Total Value
$84.58M
Total Shares
3.93M
Net Share Change
+40.0K
Activity
1 buying
Investor
Value
Shares
Weight
Change
Maverick Capital
$84.58M
3.93M
1.6%
ADD
+40.0K
(+1.0%)
Maverick Capital
$84.58M
3.93M shares
ADD
+40.0K
(+1.0%)
RCKT — Rocket Pharmaceuticals Inc - FilingSpy